maintain

[키워드] 5-OE-RU, 5-(2-oxoethylideneamino)-5-dribitylaminouracil 5-OP-RU, 5-(2-oxopropylideneamino)-5-dribitylaminouracil 6-FP, 6 formylpterin activated adaptive AHR, airway hyper responsiveness APC, antigen presenting cell Asthma BALF, bronchoalveolar lavage fluid CAP, Community-acquired pneumonia CCR, CC receptor CD, cluster of differentiation Cell CF, cystic fibrosis chronic obstructive COPD, Chronic obstructive pulmonary disease COVID-19 COVID-19, Coronavirus disease 2019 CXCR, chemokine CXC receptor cytokine receptor Disease progression DN, double negative dynamic balance Effects Evidence FEV1, forced expiratory volume in the first second GM-CSF, granulocyte–macrophage colony-stimulating factor Gzm, granzyme HIF-1α, hypoxia-inducible factor-1α HLA-DR, human leukocyte antigen DR IFN-γ, interferon-γ IL, interleukin IL4I1, interleukin-4-induced gene 1 ILCs, innate lymphoid cells Immune cell immune response Immunity Immunopathogenesis Infection Inflammation Injury iNKT, invariant natural killer T involved lung lung cancer Lung disease Lung diseases Lungs maintain MAIT, Mucosal-associated invariant T marker MHC, major histocompatibility complex microbial infection MR1, MHC-related protein 1 Mucosa-associated invariant T cells murine Pathogenesis PD-1, programmed cell death protein 1 PLZF, promyelocytic leukemia zinc finger Pneumonia potential therapeutic target Protective pulmonary disease pulmonary inflammation pulmonary tuberculosis respiratory epithelium RORγt, retinoic-acid-related orphan receptor γt SARS-CoV-2 shown SLE, systemic lupus erythematosus STAT3, signal transducer and activator of transcription 3 subset T cell T cell receptor T cells TB, Tuberculosis TCF7, transcription factor 7 TCR, T cell receptor Th, T helper these cell title TLR, Toll-like receptor TNF-α, tumor necrosis factor-α Treatment
[DOI] 10.1016/j.intimp.2021.107485 PMC 바로가기 [Article Type] Review